Products
Ciprofloxacin ABR 3 mg/ml eye and ear drops, solution
| Generic name: | Ciprofloxacin |
| АТС code: | S01AX13 |
| Composition: | Acitve substance in 1 ml solution: Ciprofloxacin 3 mg, as Ciprofloxacin hydrochloride |
| Group: | Ophthalmologicals and Otologicals |
Ciprofloxacin ABR eye and ear drops, solution (INN: ciprofloxacin) is an anti-infectious medicinal product of the second-generation fluoroquinolone group. It has a broad antibacterial spectrum and activity against a great number of the microorganisms causing eye and/or ear infections. It is suitable for the treatment of superficial infections of the eye and adjacent tissues (conjunctivitis, keratitis, corneal ulcers, etc.), as well as acute external or middle ear inflammation with secretion, due to tympanic membrane perforation.
Subgroup: Anti-infectives
Medical product subject to medical prescription
Route (s) of administration: Ocular and Auricular use
Nature and contents of container: White plastic of 5 ml, equipped with a dropper applicator and closed by a screw cap with protective ring.
One bottle in a cardboard box.
Description/Indications:
Ocular use: the product is used in adults, newborns (0 - 27 days of age), breast-fed children and infants (28 days - 23 months of age), children (2 - 11 years of age) and adolescents (12 - 16 years of age) for the treatment of corneal ulcers and superficial infections of the eye and its appendages, caused by ciprofloxacin-susceptible bacterial strains.
Auricular use: the product is used in adults and children over 1 year of age for the treatment of acute external otitis and middle ear inflammation with secretion, due to tympanic membrane perforation, caused by ciprofloxacin-susceptible bacterial strains.
Products manufactured under contract
| Generic name | Pharmaceutical form | АТС code |
|---|---|---|
| Acetylsalicylic acid | Tablets 500 mg | C01DA05 |
| Azithromycin | Powder for oral suspension 200 mg/5 ml, 20 ml | J01FA10 |
| Azithromycin | Hard capsules 250 mg | J01FA10 |
| Azithromycin | Powder for oral suspension 100 mg/5 ml, 20 ml | J01FA10 |
| Bifonazole | Cream 1%, 15 g | D01AC10 |
| Chloramphenicol | Hard capsules 250 mg | J01BA01 |
| Chloramphenicol | Ointment 2 %, 20 g | D06AX02 |
| Cinnarizine | Tablets 25 mg | N07CA02 |
| Clindamycin | Hard capsules 150 mg | J01FF01 |
| Clobetasol propionate | Cream 0,5 mg/g, 15 g | D07AD01 |
| Clobetasol propionate | Ointment 0,5 mg/g, 15 g | D07AD01 |
| Dequalinium chloride; Ascorbic acid | Compressed lozenges | C01DA05 |
| Dexamethasone, Tobramycin | Eye drops, suspension 3 mg/ml + 1 mg/ml, 5 ml | S01CA01 |
| Dimenhydrinate | Tablets 50 mg | R06AA00 |
| Doxycyclin | Hard capsules 100 mg | J01AA02 |
| Fluconazole | Hard capsules 100 mg | J02AC01 |
| Fluconazole | Hard capsules 50 mg | J02AC01 |
| Fluocinolone acetonide | Cream 0,25 mg/g, 15 g | D07AC04 |
| Fluocinolone acetonide | Ointment 0,25 mg/g, 15 g | D07AC04 |
| Fluocinolone acetonide, Neomycin | Cream 0,25 mg/g + 5 mg/g, 15 g | D07CC02 |
| Fluocinolone acetonide, Neomycin | Ointment 0,25 mg/g + 5 mg/g, 15 g | D07CC02 |
| Gentamicin | Cream 1 mg/g, 15 g | D06AX07 |
| Gentamicin | Ointment 1 mg/g, 15 g | D06AX07 |
| Gentamicin, Hydrocortisone | Cream 1 mg/g + 10 mg/g, 15 g | D07CA01 |
| Gentamicin, Hydrocortisone | Ointment 1 mg/g + 10 mg/g, 15 g | D07CA01 |
| Hydrochlorothiazide | Tablets 25 mg | C03AA03 |
| Hydrocortisone, Chloramphenicol | Eye drops, suspension 10 mg/ml + 2 mg/ml, 5 ml | S01CA03 |
| Hydrocortisone, Neomycin | Cream 10 mg/g + 3,5 mg/g, 15 g | D07CA01 |
| Hydrocortisone, Neomycin | Ointment 25 mg/g + 25 mg/g, 10 g | D07CA01 |
| Indapamide hemihydrate | Film-coated tablets 2,5 mg | C03BA11 |
| Isosorbide dinitrate | Tablets 10 mg | C01DA08 |
| Isosorbide dinitrate | Prolonged-realese tablets 20 mg | C01DA08 |
| Lincomycin | Hard capsules 500 mg | J01FF02 |
| Lovastatin | Tablets 20 mg | C10AA02 |
| Lovastatin | Tablets 40 mg | C10AA02 |
| Magnesium DL-aspartate tetrahydrate, Potassium DL-aspartate hemihydrate | Film-coated tablets 175 mg + 166 mg | A12BA30 |
| Metamizole sodium, Thiamine hydrochloride, Caffeine | Tablets 500 mg + 50 mg + 38,75 mg | N02BB52 |
| Nystatin | Tablets 500 000 IU | A07AA02 |
| Nystatin | Cream 100 000 IU/g, 15 g | D01AA01 |
| Nystatin | Ointment 100 000 IU/g, 15 g | D01AA01 |
| Oleandomycin, Dexamethasone, Indometacin | Oromucisal paste 50 mg/g + 10 mg/g + 50 mg/g, 5 ml | A01AD11 |
| Papaverine hydrochloride | Tablets 50 mg | A03AD01 |
| Pentaerithrityl tetranitrate | Tablets 10 mg | C01DA05 |
| Piracetam | Hard Capsules 400 mg | N06BX03 |
| Piracetam | Film-coated tablets 800 mg | N06BX03 |
| Propranolol hydrochloride | Tablets 20 mg | C07AA05 |
| Propranolol hydrochloride | Tablets 40 mg | C07AA05 |
| Rifampicin | Hard capsules 300 mg | J04AB02 |
| Tetracycline | Hard capsules 250 mg | J01AA07 |
| Tetracycline | Ointment 3 %, 20 g | D06AA04 |
| Tobramycin | Eye drops, solution 0,3 %, 5 ml | S01AA12 |
| Triamterene, Hydrochlorothiazide | Tablets 25 mg + 12,5 mg | C03EA01 |
| Troxerutin | Hard capsules 300 mg | C05CA04 |
New products
Aciclovir Vision 30 mg/g eye ointment
Subgroup: Antiinfectives, Antiviral products Medical product subject to medical prescription Route (s) of administration: Ocular use Nature and contents of container: The medicinal product is packe...
More
Prednisolon F 2 mg tablets
Subgroup: Glucocorticoids Medical product subject to medical prescription Route (s) of administration: Oral use Nature and contents of container: 10 (ten) tablets are packed in a PVC / PVdC / AL fo...
More
Inosipranol 500 mg and 1000 mg powder for oral solution
Subgroup: Direct acting antivirals, Other antivirals Medical product subject to medical prescription Route (s) of administration: Oral use Nature and contents of container: Inosipranol 500 m...
More
Clindavasin D 10 mg/ml cutaneous solution
Indications: Clindavasin D 10 mg/ml cutaneous solution is used to apply to the skin to treat acne vulgaris. Medical product subject to medical prescription Route (s) of administration: Clindavasin D...
More